AR004471A1 - Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen - Google Patents

Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen

Info

Publication number
AR004471A1
AR004471A1 ARP950100730A AR10073095A AR004471A1 AR 004471 A1 AR004471 A1 AR 004471A1 AR P950100730 A ARP950100730 A AR P950100730A AR 10073095 A AR10073095 A AR 10073095A AR 004471 A1 AR004471 A1 AR 004471A1
Authority
AR
Argentina
Prior art keywords
cr4r5
substituted
compounds
hydroxyl
tetrahydrothienyl
Prior art date
Application number
ARP950100730A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR004471A1 publication Critical patent/AR004471A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a compuestos de ciclohexan-1-ol, 4,4- disustituidos de fórmula (I), y composiciones farmacéuticas que incluyen dichoscompuestos de aplicación en el tratamiento de enfermedades inflamatorias y alérgicas comoinhibidores de la producción del Factor de Necrosis tumorales(FNT). En dicha fórmula los valores de R1 es -(CR4R5)n C(O) O (CR4R5)m, R6, (CR4R5)nC(O)NR4(CR4R5)m R6, ó-(CR4R5)nO(CR4R5)mR6, ó (CR4R5)rR6 en donde laporción alquilo no substituido o substituido con uno o más halógeno; m es 0 a 2; n es 0 a 4; r es 0 a 6; R4 y R5 son independientemente seleccionados H óC 1-2 alquilo;R6 es H, metil, hidroxilo, arilo, arilo halo substituido, ariloxi C1-3alquilo, ariloxi, alquilC1-3 halo, substituido, indanil, indenil, CZ 11policicloalquil, tetrahidrofuranil, furanil, tetrahidropiranil, piranil, tetrahidrotienil, tetrahidrotiopiranil, tiopiranil, C3-6 cicloalquil, o uncicloalquil C4-6 conteniendo una o dos uniones no saturadas, en dondela porción cicloalquil o heterociclican es no substituido o substituido por 1 a 3grupos metilo, un grupo etilo, o un grupo hidroxilo; proveyendo que: a) cuando R6 es hidroxilo, luego m es 2; o b) cuando R6 es hidroxilo, luego r es 2 a 6; oc)cuando R6 es 2-tetrahidropiranil, 2-tetrahidrotiopiranil,2-tetrahidrofuranil ó 2-tetrahidrotienil, luego m es 1 ó 2;o d) cuando R6 es 2 tetraidropiranil, 2-tetraidrotiopiranil, 2-tetraidrofuranil, ó 2 tetrahidrotienil, luego r es 1 a 6; e)cuando nen 1 y m en 0, luego R6 es distinto que H en (CR4R5)nO(CR4R5)mR6;X es YR2, fluor, NR4R5, o formil amina; Y es O ó S(O)m; m es 0, 1 ó 2; X2 es O ó NR8; X3 es H ó X; X4 es H, R8, OR8, CN,C(O)R8,C(O)OR8,C(O)NR8R8 ó NR8R8;R2 esindependientemente seleccionado de -CH3 ó -CH2CH3 opcionalmente substituido por 1 o más halógenos; s es 0 a 4; W es alquil de 2 a 6 carbonos, alquenil de
ARP950100730A 1995-05-31 1995-12-22 Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen AR004471A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45586695A 1995-05-31 1995-05-31

Publications (1)

Publication Number Publication Date
AR004471A1 true AR004471A1 (es) 1998-12-16

Family

ID=23810564

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100730A AR004471A1 (es) 1995-05-31 1995-12-22 Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen

Country Status (19)

Country Link
US (1) US5977122A (es)
EP (1) EP0828493A4 (es)
JP (1) JPH11507331A (es)
KR (1) KR19990022130A (es)
CN (1) CN1084621C (es)
AP (1) AP9701142A0 (es)
AR (1) AR004471A1 (es)
BG (1) BG102061A (es)
BR (1) BR9609368A (es)
CA (1) CA2222561A1 (es)
CZ (1) CZ379197A3 (es)
EA (1) EA199700451A1 (es)
HU (1) HUP9900863A3 (es)
MX (1) MX9709361A (es)
NO (1) NO975503L (es)
OA (1) OA10637A (es)
PL (1) PL323556A1 (es)
SK (1) SK159297A3 (es)
WO (1) WO1996038150A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9510257A (pt) * 1994-12-23 1997-11-04 Smithkline Beecham Corp Monômeros ciclohexan-1-óis 4,4-(di-substituidos) e compostos relacionados
MXPA02001471A (es) * 1999-08-10 2002-07-02 Smithkline Beecham Corp 4,4-diaril ciclohexanos 1,4-substituidos.
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
YU103003A (sh) 2001-06-26 2006-05-25 Abgenix Inc. Antitela za opgl
KR101614524B1 (ko) * 2013-09-30 2016-04-21 주식회사 엘지화학 중합성 액정 화합물, 이를 포함하는 액정 조성물 및 광학 필름

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3803593A (en) * 1992-04-02 1993-11-08 Smithkline Beecham Corporation Compounds
DE69331265T2 (de) * 1992-04-02 2002-08-08 Smithkline Beecham Corp., Philadelphia Verbindungen zur behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
BR9510257A (pt) * 1994-12-23 1997-11-04 Smithkline Beecham Corp Monômeros ciclohexan-1-óis 4,4-(di-substituidos) e compostos relacionados

Also Published As

Publication number Publication date
OA10637A (en) 2002-09-16
KR19990022130A (ko) 1999-03-25
AU6026896A (en) 1996-12-18
AP9701142A0 (en) 1998-01-31
BR9609368A (pt) 1999-05-18
NO975503L (no) 1998-01-28
CZ379197A3 (cs) 1998-05-13
HUP9900863A2 (hu) 1999-07-28
WO1996038150A1 (en) 1996-12-05
MX9709361A (es) 1998-02-28
SK159297A3 (en) 1998-05-06
US5977122A (en) 1999-11-02
PL323556A1 (en) 1998-04-14
CA2222561A1 (en) 1996-12-05
EA199700451A1 (ru) 1998-08-27
EP0828493A4 (en) 1998-09-02
NO975503D0 (no) 1997-11-28
JPH11507331A (ja) 1999-06-29
BG102061A (en) 1999-02-26
CN1192146A (zh) 1998-09-02
CN1084621C (zh) 2002-05-15
AU693706B2 (en) 1998-07-02
HUP9900863A3 (en) 2000-02-28
EP0828493A1 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
PE25498A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, procedimientos para su preparacion y la aplicacion de estos compuestos en medicamentos
FR2392080A1 (es)
AR004471A1 (es) Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
ES2040734T3 (es) Produccion de composiciones de magnesio que contienen haluro y alcoxi.
KR870700628A (ko) 세파로스포린 중간체를 제조하는 방법
JPS54130544A (en) Preparation of hexamethyltetraline
ES2083468T3 (es) Metodo para la preparacion de un componente catalizador para la polimerizacion de olefinas, componente catalizador de polimerizacion producido por el metodo y el uso del mismo.
MX174084B (es) Procedimiento para la preparacion de agentes antiarritmicos producto obtenido y preparacion farmaceutica que lo incluye
US3746751A (en) 1-(3-chloro-4-cycloalkylphenyl)-cyclo-alkyl-1-carboxylic acids
AR124245A1 (es) Método para preparar pralsetinib
CO5190716A1 (es) 4,4-diaril-ciclohexanos 1,4-sustituidos
BR8807437A (pt) Composicao endurecivel a base de um produto de adicao michael,processo para sua preparacao bem como sua aplicacao
MX172109B (es) , "procedimiento para la deposicion de vapor de polisilanos
Jia et al. Reductive Cleavage of SS Bond by Samarium Diiodide: A Novel Method for the Synthesis of Disulfides
AR014411A1 (es) El uso de derivados de fenil-ciclohexano sustituidos para la manufactura de un medicamento para el tratamiento profilactico de un mamifero en situacionde riesgo de desarrollar copd.
AR012550A1 (es) Metodo para preparar acidos 4-fenil-4-ciano-ciclohexanoicos sustituidos y compuestos intermediarios
JPS51136625A (en) Process for preparation of titanium double compound
SE7603958L (sv) Forfarande for framstellning av terapeutiskt aktiva foreningar
ES524742A0 (es) Un procedimiento para preparar un catalizador adecuado para la polimerizacion de olefinas
FR2336369A1 (fr) Procede d'obtention d'acide glutarique, d'acide succinique et d'acide adipique a partir d'un melange acide les contenant ainsi que lesdits acides obtenus par ce procede
JPS5217440A (en) Process for preparation of phenylacetate
JPS5251331A (en) Process for preparation of unsaturated compounds
MX3296E (es) Procedimiento para la obtencion de derivados de prostaglandina
Sammes et al. The photochemical synthesis of alkyl 2, 2-dimethyl-3-(2-methylpropenyl) aziridine-1-carboxylates and 3, 3-dimethylaziridine-1, 2-dicarboxylates from alkyl azidoformates
JPS546029A (en) Anaerobic adhesive composition